GNH USA

Europe — EMA

Nadixa (Nadifloxacin)

GNH USA supplies Nadixa (nadifloxacin), a fluoroquinolone antibiotic for acne vulgaris and other superficial bacterial skin infections.

Nadifloxacin

Request sourcing

1
Pack/s

What is Nadifloxacin?

Nadifloxacin, the active ingredient in Nadixa, is a fluoroquinolone antibiotic presented as a topical formulation for skin use. It is indicated for the treatment of acne vulgaris and other superficial bacterial skin infections in patients requiring prescription therapy.

GNH USA supplies Nadixa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nadifloxacin used for?

Nadifloxacin is a fluoroquinolone antibiotic used to treat bacterial skin conditions.

- Acne vulgaris: reduces inflammatory lesions and bacterial colonisation on the skin. - Superficial bacterial skin infections: eradicates susceptible organisms causing impetigo, folliculitis or minor wounds. - Other indicated skin infections: provides topical antibacterial activity for physician‑diagnosed bacterial dermatoses.

What are the side effects of Nadifloxacin?

Topical nadifloxacin may cause local skin reactions and, rarely, systemic hypersensitivity.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Itching: transient pruritus following use. - Burning sensation: brief warmth or stinging. - Dryness: temporary loss of moisture. - Contact dermatitis: localized eczema‑like reaction. - Redness: mild erythema.

Serious or Rare Side Effects: - Allergic reaction: urticaria, swelling, or anaphylaxis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Photosensitivity: increased sunburn risk. - Bacterial resistance: emergence of resistant strains with prolonged use. - Systemic toxicity: rare systemic absorption leading to gastrointestinal upset. - Eye involvement: accidental ocular exposure may cause irritation.

What precautions apply to Nadifloxacin?

Before prescribing Nadixa, clinicians should consider patient‑specific factors and safety measures.

- Pregnancy: safety not established; avoid unless benefit outweighs risk. - Breastfeeding: unknown excretion; use with caution. - Extensive skin damage: avoid application on large wounds, burns, or ulcerated areas. - Eyes and mucous membranes: do not apply to eyes, ears, or genital mucosa. - Allergic history: monitor for signs of hypersensitivity. - Storage: Store at room temperature: keep in original container, protect from moisture and light.

What does Nadifloxacin interact with?

Nadixa may interact with other topical agents and systemic medications.

Major Interactions (Avoid): - Concurrent systemic fluoroquinolones: additive toxicity risk. - Topical corticosteroids: may increase skin thinning and infection risk. - Other topical antibiotics: may promote bacterial resistance.

Moderate Interactions (Monitor Closely): - Antiseptic soaps or cleansers: may alter drug absorption. - Phototoxic agents: increase risk of photosensitivity reactions. - Herbal skin products: potential for irritation when combined.

Frequently asked questions

What conditions is Nadixa used to treat?+
Nadixa contains nadifloxacin, a topical fluoroquinolone antibiotic indicated for acne vulgaris and other superficial bacterial skin infections such as impetigo, folliculitis, and minor wound infections. It is prescribed when a physician determines that bacterial colonisation contributes to the skin condition.
How does nadifloxacin work to treat skin infections?+
Nadifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. Inhibiting these targets stops bacterial cell division, leading to a bactericidal effect that eliminates susceptible skin pathogens and reduces inflammation associated with infection.
What is the usual dose of Nadixa?+
The dosage of Nadixa is determined by the prescribing clinician based on the severity of the skin condition, the area to be treated, and patient factors. The prescriber will specify the amount to apply, frequency, and duration of therapy on the product label or prescription.
Is Nadixa safe to use during pregnancy or breastfeeding?+
Safety data for nadifloxacin in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless the potential benefit justifies the risk, and breastfeeding mothers should consult their healthcare provider before using the product.
How do I order Nadixa from GNH USA?+
To request Nadixa, submit an enquiry on the product page at gnh-usa.com, indicating the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Nadixa compare with other acne antibiotics?+
Nadixa (nadifloxacin) is a topical fluoroquinolone, whereas many alternative acne treatments belong to the macrolide or clindamycin classes. Fluoroquinolones have a broad spectrum against Gram‑positive and Gram‑negative bacteria and a low risk of resistance when used short‑term, but they may carry a higher potential for photosensitivity compared with macrolides.
What are the recommended storage conditions for Nadixa?+
Nadixa should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children.
How is Nadixa applied?+
Nadixa is applied topically to the affected skin area. The prescriber will advise the amount to use, typically a thin layer, and the frequency—often once or twice daily. Hands should be washed before and after application, and the treated area should be clean and dry.
What are the most serious risks associated with Nadixa?+
Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and photosensitivity leading to severe sunburn. Patients should discontinue use and seek immediate medical attention if they experience widespread rash, blistering, swelling, or breathing difficulties.
Who should not use Nadixa?+
Nadixa should not be used by individuals with a known hypersensitivity to nadifloxacin or any fluoroquinolone, on extensive open wounds, burns, or mucous membranes, and it is contraindicated in patients where the prescriber determines the risks outweigh the benefits, such as certain pregnant or lactating women.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nadifloxacin
Route
Cutaneous Use
Manufacturer
Ferrer Internacional, S.A.
Origin
EU

Related products

Nadixa

Nadixa

Nadifloxacin

Ferrer Internacional, S.A.
EU
Nadixa

Nadixa

Nadifloxacin

Ferrer Internacional, S.A.
EU
Nadixa

Nadixa

Nadifloxacin

Ferrer Internacional, S.A.
EU
Nadixa

Nadixa

Nadifloxacin

Ferrer Internacional, S.A.
EU